Predict your next investment

Antidote company logo
INTERNET | Internet Software & Services / Search

See what CB Insights has to offer

Founded Year



Series D | Alive

Total Raised


Last Raised

$23.2M | 8 mos ago

About Antidote

Antidote is a digital health company that uses precision recruitment to match the right patients with the right trials. Antidote strikes the right balance between technology and human touch to deliver patient engagement through the integration of data-driven technologies, digital expertise, deep domain experience, a diverse partner network, and personalized patient and site services.

Antidote Headquarter Location

39 Earlham Street

London, England, WC2H 9LT,

United Kingdom

+44 20 3475 8201

Latest Antidote News

For the millions of sick uninsured Americans: This Israeli startup just might have the Antidote

Aug 25, 2021

Led by industry veterans, the Israeli telehealth startup is using AI to virtually pair uninsured patients with caring physicians Dor Schwartz / • 3 min read Israeli telehealth startup Antidote Health, which uses AI technology to provide Americans with quality accessible healthcare, announces the closing of a $12 million Seed funding round. The investment was led by iAngels, Well-Tech Ventures, and Flint Capital, along with additional private investors. "The convergence of two disciplines" Antidote Health is a B2C company using artificial intelligence to provide uninsured and underinsured Americans with a virtual Health Maintenance Organization (HMO) that connects users to physicians through video calls and smart chatbots. According to the company, it chose the HMO model because of the challenging U.S. healthcare system, which has left more than 38 million Americans without proper health insurance. Many times leading the uninsured to not seek medical help when sick or wounded. The US healthcare market crossed the $4 trillion total expenditure threshold last year (about 19% of GDP). It has reached its current state in light of the existing structural separation in the market between medical service providers and insurance companies. The HMO model unites these two parts, aligning the interests between the patient, health providers and the coverer. By taking a more direct approach to coverage, Antidote is able to provide uninsured individuals with quality medical care, while only quoting them as little as $29 per month. Antidote launched its HMO model earlier this year across New York, New Jersey, Florida, Michigan, and North Carolina, with extended rollout planned for 2022. “Healthcare in the United States presents us with a great opportunity - both economically and morally. Making medical services available to a population of millions is an enormous mission," said Avihai Sodri, Antidote Health’s Co-founder and CEO. "The convergence of two disciplines - AI-based virtual healthcare and Fin-tech (Insure-tech) applicational layers is unique in the technological-medical landscape in that it provides a disruptive force in the market. The melding of advanced technologies and the social impact Antidote produces are part of our organizational DNA and manifest in every action we take.” Antidote was founded in 2020 by CEO Avihai Soudri, who previously led the innovation and business development at Leumit and served as CEO of health insurance company Vectis, which was acquired by Swiss-Re in 2019; CTO Carine-Belle Feder, previously served as an officer and commander in an elite  technology-intelligence unit in the IDF;. Dr. David Zlotnik, who serves as the Chief Medical Officer; Dr. Ben Enosh, who serves as the company's president and chairman, is a co-founder of Cyota , along with Israel Prime Minister Naftali Bennett and others, and founded Audioburst, PLYmedia and Scientific G prior to Antidote. The Israeli telehealth startup will look to use the newly raised capital to expand in the U.S., enhance marketing initiatives. Antidote Health is headquartered in New York with R&D operations based in Tel Aviv. The company has 50 doctors already under its wing and has over 30 employees, with plans to expand by the end of the year. “If there is any one industry for which COVID-19 highlighted the major gaps and necessary advances, it is the need for access to telehealth. In the wake of a global pandemic, and as an Israeli who can take for granted access to national healthcare, it is mind boggling that as many as 1 in 4 Americans do not have access to equitable and affordable healthcare. We are proud to lead Antidote Health's financing round, and to play a role in their journey to level the field for all Americans to receive adequate telemedicine," said Shelly Hod Moyal, iAngels Founding Partner. "Israel is not only a leading country in digital health, but in technology as a whole, as can be witnessed by the record breaking year we are experiencing. This expertise and ability to simplify processes coupled with Fintech advances that allow for payment from the palm of your hands has made way for Antidote Health's solution to an age-old issue." Subscribe to Geektime

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Antidote

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Antidote in 1 CB Insights research brief, most recently on Oct 5, 2021.

Expert Collections containing Antidote

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Antidote is included in 3 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

318 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Digital Health

12,256 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.

Antidote Patents

Antidote has filed 2 patents.

The 3 most popular patent topics include:

  • Clinical research
  • Clinical trials
  • Design of experiments
patents chart

Application Date

Grant Date


Related Topics



Clinical research, Clinical trials, Design of experiments, Pharmaceutical industry, Clinical data management


Application Date


Grant Date


Related Topics

Clinical research, Clinical trials, Design of experiments, Pharmaceutical industry, Clinical data management



Antidote Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Antidote Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.